J&J | JNJ - Ordinary Share Capital


J&J reported $2.41B in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 540M 1000K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Bayer EUR 982.42M 0 Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Biogen USD 146.7M 200K Sep/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
CONMED USD 30.97M 16K Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Globus Medical USD 135.06M 449K Dec/2025
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026